|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 88, 867-871, Copyright © 1984 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
HC Polk Jr
The innate limitations of sterile technique, vaccines, and antibiotics
apparent in host defense enhancement provide fertile ground for the study
of other concepts. The goals of this new research are to avoid infection or
facilitate recovery in the surgical setting and to develop new, safe, and
efficient host defense stimulants. Current laboratory work with surgically
simulated infection suggests that nonspecific host defense enhancement may
offer genuine improvement in selected clinical situations.
ARTICLES
The rediscovery of host defense enhancement
This article has been cited by other articles:
![]() |
I. M. Schwieger, C. J. Gallagher, D. C. Finlayson, W. L. Daly, and K. L. Maher Incidence of Cell-Saver contamination during cardiopulmonary bypass Ann. Thorac. Surg., July 1, 1989; 48(1): 51 - 53. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |